Since gene expression levels of NLRP6 were downregulated in the jejunum from patients with T2D, we reduced the constitutive expression levels of NLRP6 in CCL-241 cells using a specific siRNA to get insight into its mechanism of action (Fig. 5). The gene discussed is NLRP6; the disease is type 2 diabetes mellitus.